Ukr.Biochem.J. 2019; Volume 91, Issue 5, Sep-Oct, pp. 63-69


Alpha-fetoprotein as a biochemical diagnostic and prognostic marker for prolonged jaundice in newborns

O. H. Mazur, O. S. Yablon, O. S. Rubina,
M. M. Puhach, A. P. Konoplitska

National Pirogov Memorial Medical University, Vinnytsia, Ukraine;

Received: 14 January 2019; Accepted: 13 August 2019

Prolonged jaundice of newborns is a common pathology during the neonatal period. Recently, there has been a tendency toward an increased number of newborns with prolonged jaundice with duration longer than 14 days of life. According to the polyetiologic nature of neonatal jaundice, it is necessary to investigate new diagnostic signs that can predict the development of prolonged jaundice in newborns and, allow identification of new methods of differential diagnosis of neonatal jaundice, as well as decrease the frequency of this pathology. The parameters of serum alpha-fetoprotein (AFP) content in newborns with prolonged jaundice were studied. The content of AFP in blood serum was 1.7 times higher in newborns with prolonged jaundice than in newborns with jaundice for up to 14 days of life: Me = 671.1 [Q1 = 479.9; Q3 = 815.03] ng/ml and Me = 401.0 [Q1 = 284.9; Q3 = 684.0] ng/ml, respectively (P < 0.05). The content of blood serum AFP in newborns with prolonged jaundice was higher for total serum bilirubin greater than 250 μmole/l: Me = 626.2 [Q1 = 454.7; Q3 = 793.2] ng/ml which was confirmed by a strong direct correlation relationship (rxy = 0.64, P < 0.05). The results of the ROC analysis confirmed that AFP ≥ 571.7 ng/ml can identify newborns with prolonged jaundice with a sensitivity of 74.2% and a specificity of 74.5%. The area under the curve (AUC) was 0.870 (95% CI 0.804, 0.937), which confirms the good quality of the AFP model ≥ 571.7 ng/ml.

Keywords: , , ,


  1. Jardine LA, Woodgate P. Neonatal jaundice. Am Fam Physician. 2012;85: 824-825.
  2. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013 Mar;162(3):477-482. PubMed, CrossRef
  3. Maisels MJ, Clune S, Coleman K, Gendelman B, Kendall A, McManus S, Smyth M. The natural history of jaundice in predominantly breastfed infants. Pediatrics. 2014 Aug;134(2):e340-5. PubMed, CrossRef
  4. Fawaz R, Baumann U, Ekong U, Fischler B, Hadzic N, Mack CL, McLin VA, Molleston JP, Neimark E, Ng VL, Karpen SJ. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):154-168. PubMed, CrossRef
  5. Pan DH, Rivas Y. Jaundice: Newborn to Age 2 Months. Pediatr Rev. 2017 Nov;38(11):499-510.  PubMed, CrossRef
  6. Hodgson JM, van Someren VH, Smith C, Goyale A. Direct bilirubin levels observed in prolonged neonatal jaundice: a retrospective cohort study. BMJ Paediatr Open. 2018 Feb 24;2(1):e000202. PubMed, PubMedCentral, CrossRef
  7. Bhutani VK, Stark AR, Lazzeroni LC, Poland R, Gourley GR, Kazmierczak S, Meloy L, Burgos AE, Hall JY, Stevenson DK. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. 2013 Mar;162(3):477-482.e1. PubMed, CrossRef
  8. Gottesman LE, Del Vecchio MT, Aronoff SC. Etiologies of conjugated hyperbilirubinemia in infancy: a systematic review of 1692 subjects. BMC Pediatr. 2015 Nov 20;15:192. PubMed, PubMedCentral, CrossRef
  9. Fujiwara R, Maruo Y, Chen S, Tukey RH. Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia. Toxicol Appl Pharmacol. 2015 Nov 15;289(1):124-32. PubMed, PubMedCentral, CrossRef
  10. Chiou FK, Ong C, Phua KB, Chedid F, Kader A. Conjugated hyperbilirubinemia presenting in first fourteen days in term neonates. World J Hepatol. 2017 Sep 18;9(26):1108-1114.  PubMed, PubMedCentral, CrossRef
  11. Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, Shapiro SM, Watchko J, Wennberg RP, Tiribelli C, Coda Zabetta CD. Neonatal Jaundice in Low- and Middle-Income Countries: Lessons and Future Directions from the 2015 Don Ostrow Trieste Yellow Retreat. Neonatology. 2016;110(3):172-80. PubMed, CrossRef
  12. Parvathamma PA, Brockbank EP, Abourahma Y. Three-year experience with prolonged neonatal jaundice screening in a district general hospital. Int J Contemp Pediatr. 2017; 4(1): 1-4. CrossRef
  13. Flaherman VJ, Maisels MJ. ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017. Breastfeed Med. 2017 Jun;12(5):250-257. PubMed, CrossRef
  14. Scrafford CG, Mullany LC, Katz J, Khatry SK, LeClerq SC, Darmstadt GL, Tielsch JM. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal. Trop Med Int Health. 2013 Nov;18(11):1317-28. PubMed, PubMedCentral, CrossRef
  15. Zhou S, Wang Z, He F, Qiu H, Wang Y, Wang H, Zhou J, Zhou J, Cheng G, Zhou W, Xu R, Wang M. Association of serum bilirubin in newborns affected by jaundice with gut microbiota dysbiosis. J Nutr Biochem. 2019 Jan;63:54-61. PubMed, CrossRef
  16. Tuzun F, Kumral A, Duman N, Ozkan H. Breast milk jaundice: effect of bacteria present in breast milk and infant feces. J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):328-32. PubMed, CrossRef
  17. Paul SP, Barnden J, Adams HL. Objective Assessment of Stool Color in Neonates with Prolonged Jaundice. Indian J Pediatr. 2017 May;84(5):415-416. PubMed, CrossRef
  18. Martín V, Maldonado-Barragán A, Moles L, Rodriguez-Baños M, Campo RD, Fernández L, Rodríguez JM, Jiménez E. Sharing of bacterial strains between breast milk and infant feces. J Hum Lact. 2012 Feb;28(1):36-44. PubMed, CrossRef
  19. Kuzdan C, Çoban AÇ, İnce Z, Can G, Türkoğlu Ü. The umbilical cord alpha-fetoprotein levels for predicting hyperbilirubinemia in term neonates. J Matern Fetal Neonatal Med. 2014 Feb;27(3):265-9.  PubMed, CrossRef
  20. Yablon O, Mazur O. Alpha-fetoprotein and prolonged neonatal jaundice. Neonatol Surg Perinat Med. 2016;VI(4(22)): 23-27. (In Ukrainian).
  21. Lenchenko AV. Clinical and paraclinical characteristics of children with prolonged conjugational jaundice. Perinatol Pediatr. 2013;3(55):9-12. (In Ukrainian).
  22. Sharma S, Dhakal I. Complications among Mothers and New Born Due to Delivery Process in Rupandehi District Nepal. J Nepal Health Res Counc. 2018 Jul 3;16(2):190-194. PubMed, CrossRef
  23. Tavakolizadeh R, Izadi A, Seirafi G, Khedmat L, Mojtahedi SY. Maternal risk factors for neonatal jaundice: a hospital-based cross-sectional study in Tehran. Eur J Transl Myol. 2018 Jul 10;28(3):7618. PubMed, PubMedCentral, CrossRef
  24. Norman M, Åberg K, Holmsten K, Weibel V, Ekéus C. Predicting Nonhemolytic Neonatal Hyperbilirubinemia. Pediatrics. 2015 Dec;136(6):1087-94. PubMed, CrossRef
  25. Özdek S, Kul M, Barış Akcan A, Çekmez F, Aydemir G, Aydınöz S, Karademir F, Süleymanoğlu S. The effect of the pre-pregnancy weight of the mother and the gestational weight gain on the bilirubin level of term newborn. J Matern Fetal Neonatal Med. 2016;29(15):2434-7. PubMed, CrossRef
  26. Garosi E, Mohammadi F, Ranjkesh F. The relationship between neonatal jaundice and maternal and neonatal factors. Iranian J Neonatol. 2016;7(1): 37-40.

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.